Empire BlueCross BlueShield Announces Plan to Extend Health Care Coverage for Many Young Americans

Tuesday, April 20, 2010 Health Insurance News J E 4

NEW YORK, April 19 Empire BlueCross BlueShield, New York's largest health insurer, announced today that it will take steps to prevent a gap in coverage that could leave many young Americans uninsured.

Each year in June, many individuals are no longer eligible as dependents on their parents' insurance policies because of their age, student status or other factors. Health care reform legislation, signed into law last month, will extend the dependent age for coverage to 26 for plan years beginning September 23, 2010. As such, many individuals would face a coverage gap during the months before this provision is fully implemented.

As a proactive measure to assist its members, Empire will allow young men and women to remain on their parents' policies even before this health care reform provision takes effect. Beginning June 1, Empire will automatically retain these young individuals on their parents' policies in both fully insured group and individual health plans. Self insured clients and members will have the option of not offering this extended coverage.

"Protecting access to health benefits for members is our first priority," said Empire's President and CEO, Mark Wagar. "We are pleased to lead the way in advancing the intent of health care reform and increasing access to affordable, quality coverage."

Empire BlueCross BlueShield

Empire BlueCross BlueShield (Empire) is the trade name of Empire HealthChoice Assurance, Inc., and Empire Blue Cross Blue Shield HMO is the trade name of Empire HealthChoice HMO, Inc., independent licensees of the Blue Cross Blue Shield Association, serving residents and businesses in the 28 eastern and southeastern counties of New York State. Additional information about Empire is available at

SOURCE Empire BlueCross BlueShield


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Amgen Preclinical Study Demonstrated Anti-Tumor Ac...
Axela Inc. announces bilateral agreement with diag...